Univariate analysis | HR | 95 % CI | p value |
---|---|---|---|
Age | 1 | 0.98 to 1.03 | 0.80 |
Racea | |||
White | 1 | Reference | |
African-American/Black | 1.28 | 0.92 to 1.78 | 0.15 |
Serum PSA | 1.03 | 1.02 to 1.04 | <0.001 |
Clinical stagea | |||
T1c | 1 | Reference | |
T2a | 1.57 | 1.01 to 2.45 | 0.04 |
T2b | 2.70 | 1.24 to 5.88 | 0.01 |
> T2c | 0.72 | 0.18 to 2.92 | 0.64 |
Year of Prostatectomy | 1.01 | 0.98 to 1.05 | 0.55 |
Clinical Gleason scorea | |||
≤ 6 | 1 | Reference | |
7 | 2.34 | 1.61 to 3.39 | <0.001 |
≥ 8 | 4.63 | 3.12 to 6.87 | <0.001 |
Body mass index, categoricala | |||
< 25 kg/m2 | 1 | Reference | |
25 kg/m2 to <30 kg/m2 | 1.99 | 1.13 to 3.50 | 0.02 |
≥ 30 kg/m2 | 2.89 | 1.62 to 5.16 | <0.001 |
Multivariate analysis | |||
Age | 0.99 | 0.96 to 1.01 | 0.31 |
Racea | |||
White | 1 | Reference | |
African-American/Black | 0.67 | 0.43 to 1.04 | 0.07 |
Serum PSA | 1.02 | 1.01 to 1.03 | <0.001 |
Clinical stagea | |||
T1c | 1 | Reference | |
T2a | 1.75 | 1.11 to 2.75 | 0.015 |
T2b | 0.91 | 0.36 to 2.30 | 0.84 |
> T2c | 0.27 | 0.06 to 1.14 | 0.07 |
Year of Prostatectomy | 1.02 | 0.99 to 1.06 | 0.20 |
Clinical Gleason scorea | |||
≤ 6 | 1 | Reference | |
7 | 2.69 | 1.71 to 4.24 | <0.001 |
≥ 8 | 7.27 | 4.26 to 12.42 | <0.001 |
Body mass index, categoricala | |||
< 25 kg/m 2 | 1 | Reference | |
25 kg/m 2 to <30 kg/m 2 | 1.97 | 0.97 to 4.01 | 0.06 |
≥ 30 kg/m 2 | 2.56 | 1.24 to 5.29 | 0.01 |